27 May 2025 : Original article
Impact of Preoperative Treatment on Donor Hepatic Steatosis in Living Donor Liver Transplantation
Ahmet Atasever
ABCEF 1, Sinan Efe Yazıcı ABEF 1*, Tolga Şahin ABCF 1, Yıldıray Yuzer A 2
DOI: 10.12659/AOT.947772
Ann Transplant 2025; 30:e947772
Table 2 Preoperative biochemical parameters.
| Patients receiving fatty liver treatment (n: 14)(mean±SD) | Patients not receiving fatty liver treatment (n: 20)(mean±SD) | P value | |
|---|---|---|---|
| Total cholesterol | 205±42 | 189±43 | >0.05 |
| HDL | 38±6 | 43±9 | >0.05 |
| LDL | 139±36 | 129±37 | >0.05 |
| VLDL | 32±21 | 19±11 | |
| Triglyceride | 161±107 | 98±58 | |
| AST | 23±9 | 21±4 | >0.05 |
| ALT | 33±24 | 20±10 | |
| ALP | 66±11 | 65±19 | >0.05 |
| GGT | 25±9 | 24±13 | >0.05 |
| Total bilirubin | 0.6±0.1 | 0.7±0.2 | >0.05 |
| Direct bilirubin | 0.2±0.1 | 0.2±0.06 | >0.05 |
| INR | 1.00±0.08 | 0.96±0.06 | >0.05 |